# FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

> **NCT05928507** · — · UNKNOWN · sponsor: **Baebies, Inc.** · enrollment: 2500 (estimated)

## Conditions studied

- Influenza A
- Influenza Type B
- SARS CoV 2 Infection
- RSV Infection

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections

## Key facts

- **NCT ID:** NCT05928507
- **Lead sponsor:** Baebies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-02
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-03-30
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928507, "FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05928507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*